Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03465137 · ClinicalTrials.gov registry record · NA

Using the Neuroscience of Fear Extinction for Anxiety Reduction

A NA study, sponsored by Stanford University.

Terminated
Registry status
NA
Development phase
32
Enrollment target

NCT03465137: Clinical Trial NA study, sponsored by Stanford University.

NCT03465137 is a NA study that was terminated before completion, run by Stanford University. The registered enrollment target is 32 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03465137, a NA study, was terminated before completion, sponsored by Stanford University.

TERMINATED
Registry status
NA
Development phase
32 participants
Enrollment target

Study Summary

Social anxiety disorder affects as many as 12% of Americans, resulting in significant distress and disability. Although exposure therapy is one of the best treatments available, as many as 25% of patients do not respond and we do not know why. Extinction learning is thought to be the mechanism of exposure therapy, and the neuroscience of extinction learning has advanced significantly since exposure therapy was developed; however, there has been little application towards improved clinical outcomes. This project aims to improve exposure therapy response for patients with social anxiety disorder by directly linking exposure therapy response to the neurobiology of extinction learning. It also aims to increase our scientific understanding of how brain circuits work to support extinction learning. To do this, 80 adults with social anxiety disorder will randomly be assigned to either receive exposure therapy right away, or to wait before therapy. Participants will all complete a functional magnetic resonance imaging scan to assess extinction learning before the therapy.

Interventions

  • BEHAVIORAL Coordinated Anxiety Learning and Management (CALM)

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2018-01-14
Est. Completion 2021-09-30
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT03465137

The ClinicalTrials.gov registry entry for NCT03465137 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Coordinated Anxiety Learning and Management (CALM) is the first listed.

NCT03465137 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03465137 about?

NCT03465137 is a clinical study titled "Using the Neuroscience of Fear Extinction for Anxiety Reduction". Social anxiety disorder affects as many as 12% of Americans, resulting in significant distress and disability. Although exposure therapy is one of the best treatments available, as many as 25% of patients do not respond and we do not know why. Extinction learning is thought to be the mechanism of ex...

What is the current status of trial NCT03465137?

This trial is currently terminated. It is a NA study. The enrollment target is 32 participants. The study started on 2018-01-14. Estimated completion is 2021-09-30.

What interventions are being tested in trial NCT03465137?

The interventions under investigation include: Coordinated Anxiety Learning and Management (CALM) (BEHAVIORAL).

Who is sponsoring clinical trial NCT03465137?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.